Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.1B | 13.6B | 13.6B | 13.4B |
Cost of revenue | 12.5B | 12.5B | 12.5B | 12.5B |
Gross profit | 600M | 1.1B | 1.1B | 878M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 500M | 515M | 535M | 537M |
Other operating expenses | — | — | — | — |
Operating income | 100M | 580M | 525M | 341M |
Non operating interest income | ||||
Income | 17M | 25M | 29M | 36M |
Expense | 110M | 120M | 130M | 135M |
Other income expense | 23M | -7M | 51M | 11M |
Pretax income | 30M | 478M | 475M | 253M |
Tax provision | 16M | 112M | 111M | 57M |
Net income | 14M | 366M | 364M | 196M |
Basic EPS | 0.0 | 1.0 | 1.0 | 0.6 |
Diluted EPS | 0.0 | 1.0 | 1 | 0.5 |
Basic average shares | 350M | 355M | 346.6M | 347.3M |
Diluted average shares | 350M | 357M | 357M | 353.7M |
EBITDA | 492M | 946M | 923M | 748M |
Net income from continuing op. | 14M | 366M | 364M | 196M |
Minority interests | -7M | -7M | -7M | -5M |
Preferred stock dividends | — | — | — | — |